CKDXF OTC
Ceryvyn Therapeutics Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -97.7%
1Y: -97.7%
3Y: -97.6%
5Y: -99.1%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$22M
-61.1% ▼
5Y CAGR: -34.6%
Total Liabilities
$2M
-99.4% ▼
5Y CAGR: -17.4%
Shareholders Equity
$20M
+110.2% ▲
5Y CAGR: -35.3%
Cash & Investments
$21M
-57.1% ▼
5Y CAGR: -33.3%
Total Debt
$0
-100.0% ▼
Net Debt
-$21M
-110.4% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $65M | $134M | $172M | $48M | $21M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $65M | $134M | $172M | $48M | $21M |
| Net Receivables | $0 | $7M | $12M | $8M | $760K |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $3M | $0 | $0 | $0 |
| Total Current Assets | $87M | $148M | $188M | $57M | $22M |
| Property, Plant & Equip. | $41K | $303K | $132K | $0 | $0 |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $160K | $80K | $467K | $0 | $0 |
| Total Non-Current Assets | $201K | $383K | $599K | $0 | $0 |
| Total Assets | $87M | $148M | $189M | $57M | $22M |
| — Liabilities — | |||||
| Accounts Payable | $11M | $18M | $38M | $10M | $2M |
| Short-Term Debt | $0 | $0 | $0 | $248M | $0 |
| Deferred Revenue | $0 | $73K | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $753K | $26M | $299K | $0 |
| Total Current Liabilities | $18M | $28M | $64M | $258M | $2M |
| Long-Term Debt | $0 | $0 | $142M | $0 | $0 |
| Other Non-Current Liab. | $41K | $129M | $59M | $0 | $0 |
| Total Non-Current Liabilities | $41K | $129M | $201M | $0 | $0 |
| Total Liabilities | $18M | $157M | $265M | $258M | $2M |
| — Equity — | |||||
| Common Stock | $342M | $482M | $466M | $497M | $507M |
| Retained Earnings | -$315M | -$540M | -$580M | -$742M | -$525M |
| Accumulated OCI | $43M | $49M | $38M | $44M | $39M |
| Total Stockholders Equity | $70M | -$9M | -$76M | -$201M | $20M |
| Total Liabilities & Equity | $87M | $148M | $189M | $57M | $22M |
| — Key Metrics — | |||||
| Total Debt | $0 | $273K | $142M | $0 | $0 |
| Net Debt | -$65M | -$134M | -$31M | -$48M | -$21M |
| Total Investments | $0 | $0 | $0 | $0 | $0 |